Arkolith/Insider Trading/AVDL/Form 4

McHugh Thomas S

Chief Financial OfficerAVADEL PHARMACEUTICALS PLC (AVDL) · full profile →Form 4 · filed Jan 16, 2024
Net Buying
Open-Market Buys
$29K
Open-Market Sells
$0
Net Open-Market Flow
$29K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 16, 2024Buy(P)2K$14.50$29K81K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-004132) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML